Viewing Study NCT01068756


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-01 @ 3:31 PM
Study NCT ID: NCT01068756
Status: TERMINATED
Last Update Posted: 2016-10-17
First Post: 2010-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy Subjects
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module